Atezolizumab With Neoadjuvant Chemotherapy for Patients With Newly-Diagnosed Advanced-Stage Ovarian Cancer

NCT03394885 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Ovarian Cancer
Ovarian Neoplasms

Interventions

DRUG: Atezolizumab
DRUG: Carboplatin
DRUG: Paclitaxel
DRUG: Bevacizumab

Sponsor

Duke University

Collaborators

[object Object]
[object Object]